Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Dibb

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncogene|September 20, 2005
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistanceJ R Taylor, N Brownlow, J Domin, et al.
Journal of Molecular Biology|February 5, 1989
Sequence analysis of the complete Caenorhabditis elegans myosin heavy chain gene familyN J Dibb, I N Maruyama, M Krause, et al.
Leukemia|November 1, 1994
Evidence that ras and myc mediate the synergy between SCF or M-CSF and other haemopoietic growth factorsD A Baker, J Maher, I A Roberts, et al.
Oncogene|October 5, 1995
Selection of activating mutations of c-fms in FDC-P1 cellsH R Glover, D A Baker, A Celetti, et al.
British Journal of Cancer|March 1, 1996
Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, IshikawaS Takeda, W P Soutter, N J Dibb, et al.
Oncogene|May 26, 1999
Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradationG M Morley, M Uden, W J Gullick, et al.
Leukemia|September 12, 2008
Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptorN Brownlow, C Mol, C Hayford, et al.
Oncogene|October 19, 1995
Evidence for cell-specific differences in transformation by N-, H- and K-rasJ Maher, D A Baker, M Manning, et al.
Nature|May 18, 2001
Mae mediates MAP kinase phosphorylation of Ets transcription factors in DrosophilaD A Baker, B Mille-Baker, S M Wainwright, et al.
Molecular Human Reproduction|February 13, 2001
Quantitative measurement of transcript levels throughout human preimplantation development: analysis of hypoxanthine phosphoribosyl transferaseD M Taylor, A H Handyside, P F Ray, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncogene|September 20, 2005
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistanceJ R Taylor, N Brownlow, J Domin, et al.
Journal of Molecular Biology|February 5, 1989
Sequence analysis of the complete Caenorhabditis elegans myosin heavy chain gene familyN J Dibb, I N Maruyama, M Krause, et al.
Leukemia|November 1, 1994
Evidence that ras and myc mediate the synergy between SCF or M-CSF and other haemopoietic growth factorsD A Baker, J Maher, I A Roberts, et al.
Oncogene|October 5, 1995
Selection of activating mutations of c-fms in FDC-P1 cellsH R Glover, D A Baker, A Celetti, et al.
British Journal of Cancer|March 1, 1996
Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, IshikawaS Takeda, W P Soutter, N J Dibb, et al.
Oncogene|May 26, 1999
Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradationG M Morley, M Uden, W J Gullick, et al.
Leukemia|September 12, 2008
Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptorN Brownlow, C Mol, C Hayford, et al.
Oncogene|October 19, 1995
Evidence for cell-specific differences in transformation by N-, H- and K-rasJ Maher, D A Baker, M Manning, et al.
Nature|May 18, 2001
Mae mediates MAP kinase phosphorylation of Ets transcription factors in DrosophilaD A Baker, B Mille-Baker, S M Wainwright, et al.
Molecular Human Reproduction|February 13, 2001
Quantitative measurement of transcript levels throughout human preimplantation development: analysis of hypoxanthine phosphoribosyl transferaseD M Taylor, A H Handyside, P F Ray, et al.
Pageof 3